TABLE OF CONTENTS
1 EXECUTIVE SUMMARY
2 MARKET INTRODUCTION
2.1 DEFINITION
2.2 SCOPE OF THE STUDY
2.3 RESEARCH OBJECTIVE
2.4 MARKET STRUCTURE
3 RESEARCH METHODOLOGY
3.1 OVERVIEW
3.2 DATA FLOW
3.2.1 DATA MINING PROCESS
3.3 PURCHASED DATABASE:
3.4 SECONDARY SOURCES:
3.4.1 SECONDARY RESEARCH DATA FLOW:
3.5 PRIMARY RESEARCH:
3.5.1 PRIMARY RESEARCH DATA FLOW:
3.6 APPROACHES FOR MARKET SIZE ESTIMATION:
3.6.1 REVENUE ANALYSIS APPROACH
3.7 DATA FORECASTING
3.7.1 DATA FORECASTING TYPE
3.8 DATA MODELING
3.8.1 MICROECONOMIC FACTOR ANALYSIS:
3.8.2 DATA MODELING:
3.9 TEAMS AND ANALYST CONTRIBUTION
4 MARKET DYNAMICS
4.1 INTRODUCTION
4.2 DRIVERS
4.2.1 INCREASING INCIDENCES OF BLOOD ACQUIRED BLEEDING DISORDERS
4.2.2 RISING PRODUCT LAUNCH BY MARKET PLAYERS
4.3 RESTRAINTS
4.3.1 VOLUNTARY PRODUCT RECALL BY MARKET PLAYERS
4.3.2 HIGH COST ASSOCIATED WITH COAGULATION ANALYZER
4.4 OPPORTUNITY
4.4.1 FAVOURABLE GOVERNMENT INITIATIVES ASSOCIATED WITH BLEEDING DISORDERS
4.4.2 GROWING GERIATRIC POPULATION ACROSS THE GLOBE
5 MARKET FACTOR ANALYSIS
5.1 PORTER'S FIVE FORCES MODEL
5.1.1 THREAT OF NEW ENTRANTS
5.1.2 BARGAINING POWER OF SUPPLIERS
5.1.3 THREAT OF SUBSTITUTES
5.1.4 BARGAINING POWER OF BUYERS
5.1.5 INTENSITY OF RIVALRY
5.2 IMPACT OF COVID-19 ON THE GLOBAL BLOOD COAGULATION TESTING MARKET
6 GLOBAL BLOOD COAGULATION TESTING MARKET, BY PRODUCT
6.1 OVERVIEW
6.2 CONSUMABLES
6.2.1 REAGENTS
6.2.2 TEST KITS
6.3 INSTRUMENTS
7 GLOBAL BLOOD COAGULATION TESTING MARKET, BY APPLICATION
7.1 OVERVIEW
7.2 ACQUIRED BLEEDING DISORDERS
7.3 INHERITED BLEEDING DISORDERS
7.3.1 HEMOPHILIA
7.3.2 VON WILLEBRAND DISEASE
7.3.3 OTHERS
8 GLOBAL BLOOD COAGULATION TESTING MARKET, BY TEST TYPE
8.1 OVERVIEW
8.2 PROTHROMBIN TIME TESTING
8.3 ACTIVATED PARTIAL THROMBOPLASTIN TIME (APTT) TESTING
8.4 FIBRINOGEN TESTING
8.5 ACTIVATED CLOTTING TIME TESTING
8.6 PLATELET FUNCTION TESTS
8.7 OTHERS
9 GLOBAL BLOOD COAGULATION TESTING MARKET, BY END USER
9.1 OVERVIEW
9.2 HOSPITALS AND CLINICS
9.3 DIAGNOSTIC CENTERS
9.4 AMBULATORY CARE CENTERS
9.5 OTHERS
10 GLOBAL BLOOD COAGULATION TESTING MARKET, BY REGION
10.1 OVERVIEW
10.2 NORTH AMERICA
10.2.1 US
10.2.2 CANADA
10.3 EUROPE
10.3.1 GERMANY
10.3.2 FRANCE
10.3.3 UK
10.3.4 ITALY
10.3.5 SPAIN
10.3.6 REST OF EUROPE
10.4 ASIA-PACIFIC
10.4.1 CHINA
10.4.2 INDIA
10.4.3 JAPAN
10.4.4 AUSTRALIA
10.4.5 SOUTH KOREA
10.4.6 REST OF ASIA-PACIFIC
10.5 REST OF THE WORLD
10.5.1 MIDDLE EAST
10.5.2 AFRICA
10.5.3 LATIN AMERICA
11 COMPETITIVE LANDSCAPE
11.1 INTRODUCTION
11.2 MARKET SHARE ANALYSIS, 2023
11.3 COMPETITOR DASHBOARD
11.4 PUBLIC PLAYERS STOCK SUMMARY
11.5 COMPARATIVE ANALYSIS: KEY PLAYERS FINANICAL
11.6 KEY DEVELOPMENTS & GROWTH STRATEGIES
11.6.1 EXPANSION
11.6.2 AGREEMENT
11.6.3 PRODUCT LAUNCH
11.6.4 APPROVAL
11.6.5 AQUISITION
11.6.6 PRODUCT RECOGNITION
12 COMPANY PROFILES
12.1 F. HOFFMANN-LA ROCHE LTD.
12.1.1 COMPANY OVERVIEW
12.1.2 FINANCIAL OVERVIEW
12.1.3 PRODUCTS OFFERED
12.1.4 KEY DEVELOPMENTS
12.1.5 SWOT ANALYSIS
12.1.6 KEY STRATEGIES
12.2 MICROPOINT BIOTECHNOLOGIES CO., LTD.
12.2.1 COMPANY OVERVIEW
12.2.2 FINANCIAL OVERVIEW
12.2.3 PRODUCTS OFFERED
12.2.4 KEY DEVELOPMENTS
12.2.5 KEY STRATEGIES
12.3 HOMOSONICS LLC
12.3.1 COMPANY OVERVIEW
12.3.2 FINANCIAL OVERVIEW
12.3.3 PRODUCTS OFFERED
12.3.4 KEY DEVELOPMENTS
12.3.5 KEY STRATEGIES
12.4 HELENA LABORATORIES CORPORATION
12.4.1 COMPANY OVERVIEW
12.4.2 FINANCIAL OVERVIEW
12.4.3 PRODUCTS OFFERED
12.4.4 KEY DEVELOPMENTS
12.4.5 KEY STRATEGIES
12.5 SYSMEX CORPORATION
12.5.1 COMPANY OVERVIEW
12.5.2 FINANCIAL OVERVIEW
12.5.3 PRODUCTS OFFERED
12.5.4 KEY DEVELOPMENTS
12.5.5 SWOT ANALYSIS
12.5.6 KEY STRATEGIES
12.6 WERFEN
12.6.1 COMPANY OVERVIEW
12.6.2 FINANCIAL OVERVIEW
12.6.3 PRODUCTS OFFERED
12.6.4 KEY DEVELOPMENTS
12.6.5 KEY STRATEGIES
12.7 MERIL LIFE SCIENCES PVT. LTD.
12.7.1 COMPANY OVERVIEW
12.7.2 FINANCIAL OVERVIEW
12.7.3 PRODUCTS OFFERED
12.7.4 KEY DEVELOPMENTS
12.7.5 KEY STRATEGIES
12.8 THERMO FISHER SCIENTIFIC, INC.
12.8.1 COMPANY OVERVIEW
12.8.2 FINANCIAL OVERVIEW
12.8.3 PRODUCTS OFFERED
12.8.4 KEY DEVELOPMENTS
12.8.5 SWOT ANALYSIS
12.8.6 KEY STRATEGIES
12.9 SIEMENS HEALTHINEERS AG
12.9.1 COMPANY OVERVIEW
12.9.2 FINANCIAL OVERVIEW
12.9.3 PROUDCTS OFFERED
12.9.4 KEY DEVELOPMENTS
12.9.5 SWOT ANALYSIS
12.9.6 KEY STRATEGIES
13 DATA CITATIONS
LIST OF TABLES
TABLE 1 QFD MODELING FOR MARKET SHARE ASSESSMENT
TABLE 2 GLOBAL BLOOD COAGULATION TESTING MARKET, BY PRODUCT, 2019–2032 (USD BILLION)
TABLE 3 GLOBAL BLOOD COAGULATION TESTING MARKET, FOR CONSUMABLES, BY REGION, 2019–2032 (USD BILLION)
TABLE 4 GLOBAL BLOOD COAGULATION TESTING MARKET, FOR CONSUMABLES, BY TYPE, 2019–2032 (USD BILLION)
TABLE 5 GLOBAL BLOOD COAGULATION TESTING MARKET, FOR REAGENTS, BY REGION, 2019–2032 (USD BILLION)
TABLE 6 GLOBAL BLOOD COAGULATION TESTING MARKET, FOR TEST KITS, BY REGION, 2019–2032 (USD BILLION)
TABLE 7 GLOBAL BLOOD COAGULATION TESTING MARKET, FOR INSTRUMENTS, BY REGION, 2019–2032 (USD BILLION)
TABLE 8 GLOBAL BLOOD COAGULATION TESTING MARKET, BY APPLICATION, 2019–2032 (USD BILLION)
TABLE 9 GLOBAL BLOOD COAGULATION TESTING MARKET, FOR ACQUIRED BLEEDING DISORDERS, BY REGION, 2019–2032 (USD BILLION)
TABLE 10 GLOBAL BLOOD COAGULATION TESTING MARKET, FOR INHERITED BLEEDING DISORDERS, BY REGION, 2019–2032 (USD BILLION)
TABLE 11 GLOBAL BLOOD COAGULATION TESTING MARKET, FOR INHERITED BLEEDING DISORDERS, BY TYPE, 2019–2032 (USD BILLION)
TABLE 12 GLOBAL BLOOD COAGULATION TESTING MARKET, FOR HEMOPHILIA, BY REGION, 2019–2032 (USD BILLION)
TABLE 13 GLOBAL BLOOD COAGULATION TESTING MARKET, FOR VON WILLEBRAND DISEASE, BY REGION, 2019–2032 (USD BILLION)
TABLE 14 GLOBAL BLOOD COAGULATION TESTING MARKET, FOR OTHERS, BY REGION, 2019–2032 (USD BILLION)
TABLE 15 GLOBAL BLOOD COAGULATION TESTING MARKET, BY TEST TYPE, 2019–2032 (USD BILLION)
TABLE 16 GLOBAL BLOOD COAGULATION TESTING MARKET, FOR PROTHROMBIN TIME TESTING, BY REGION, 2019–2032 (USD BILLION)
TABLE 17 GLOBAL BLOOD COAGULATION TESTING MARKET, FOR ACTIVATED PARTIAL THROMBOPLASTIN TIME (APTT) TESTING, BY REGION, 2019–2032 (USD BILLION)
TABLE 18 GLOBAL BLOOD COAGULATION TESTING MARKET, FOR FIBRINOGEN TESTING, BY REGION, 2019–2032 (USD BILLION)
TABLE 19 GLOBAL BLOOD COAGULATION TESTING MARKET, FOR ACTIVATED CLOTTING TIME TESTING, BY REGION, 2019–2032 (USD BILLION)
TABLE 20 GLOBAL BLOOD COAGULATION TESTING MARKET, FOR PLATELET FUNCTION TESTS, BY REGION, 2019–2032 (USD BILLION)
TABLE 21 GLOBAL BLOOD COAGULATION TESTING MARKET, FOR OTHERS, BY REGION, 2019–2032 (USD BILLION)
TABLE 22 GLOBAL BLOOD COAGULATION TESTING MARKET, BY END USER, 2019–2032 (USD BILLION)
TABLE 23 GLOBAL BLOOD COAGULATION TESTING MARKET, FOR HOSPITALS AND CLINICS, BY REGION, 2019–2032 (USD BILLION)
TABLE 24 GLOBAL BLOOD COAGULATION TESTING MARKET, FOR DIAGNOSTIC CENTERS, BY REGION, 2019–2032 (USD BILLION)
TABLE 25 GLOBAL BLOOD COAGULATION TESTING MARKET, FOR AMBULATORY CARE CENTERS, BY REGION, 2019–2032 (USD BILLION)
TABLE 26 GLOBAL BLOOD COAGULATION TESTING MARKET, FOR OTHERS, BY REGION, 2019–2032 (USD BILLION)
TABLE 27 GLOBAL BLOOD COAGULATION TESTING MARKET, BY REGION, 2019–2032 (USD BILLION)
TABLE 28 NORTH AMERICA: BLOOD COAGULATION TESTING MARKET, BY COUNTRY, 2019–2032 (USD BILLION)
TABLE 29 NORTH AMERICA: BLOOD COAGULATION TESTING MARKET, BY PRODUCT, 2019–2032 (USD BILLION)
TABLE 30 NORTH AMERICA: BLOOD COAGULATION TESTING MARKET, FOR CONSUMABLES, BY TYPE, 2019–2032 (USD BILLION)
TABLE 31 NORTH AMERICA: BLOOD COAGULATION TESTING MARKET, BY APPLICATION, 2019–2032 (USD BILLION)
TABLE 32 NORTH AMERICA: BLOOD COAGULATION TESTING MARKET, FOR INHERITED BLEEDING DISORDERS, BY TYPE, 2019–2032 (USD BILLION)
TABLE 33 NORTH AMERICA: BLOOD COAGULATION TESTING MARKET, BY TEST TYPE, 2019–2032 (USD BILLION)
TABLE 34 NORTH AMERICA: BLOOD COAGULATION TESTING MARKET, BY END USER, 2019–2032 (USD BILLION)
TABLE 35 US: BLOOD COAGULATION TESTING MARKET, BY PRODUCT, 2019–2032 (USD BILLION)
TABLE 36 US: BLOOD COAGULATION TESTING MARKET, FOR CONSUMABLES, BY TYPE, 2019–2032 (USD BILLION)
TABLE 37 US: BLOOD COAGULATION TESTING MARKET, BY APPLICATION, 2019–2032 (USD BILLION)
TABLE 38 US: BLOOD COAGULATION TESTING MARKET, FOR INHERITED BLEEDING DISORDERS, BY TYPE, 2019–2032 (USD BILLION)
TABLE 39 US: BLOOD COAGULATION TESTING MARKET, BY TEST TYPE, 2019–2032 (USD BILLION)
TABLE 40 US: BLOOD COAGULATION TESTING MARKET, BY END USER, 2019–2032 (USD BILLION)
TABLE 41 CANADA: BLOOD COAGULATION TESTING MARKET, BY PRODUCT, 2019–2032 (USD BILLION)
TABLE 42 CANADA: BLOOD COAGULATION TESTING MARKET, FOR CONSUMABLES, BY TYPE, 2019–2032 (USD BILLION)
TABLE 43 CANADA: BLOOD COAGULATION TESTING MARKET, BY APPLICATION, 2019–2032 (USD BILLION)
TABLE 44 CANADA: BLOOD COAGULATION TESTING MARKET, FOR INHERITED BLEEDING DISORDERS, BY TYPE, 2019–2032 (USD BILLION)
TABLE 45 CANADA: BLOOD COAGULATION TESTING MARKET, BY TEST TYPE, 2019–2032 (USD BILLION)
TABLE 46 CANADA: BLOOD COAGULATION TESTING MARKET, BY END USER, 2019–2032 (USD BILLION)
TABLE 47 EUROPE: BLOOD COAGULATION TESTING MARKET, BY COUNTRY, 2019–2032 (USD BILLION)
TABLE 48 EUROPE: BLOOD COAGULATION TESTING MARKET, BY PRODUCT, 2019–2032 (USD BILLION)
TABLE 49 EUROPE: BLOOD COAGULATION TESTING MARKET, FOR CONSUMABLES, BY TYPE, 2019–2032 (METRIC TON)
TABLE 50 EUROPE: BLOOD COAGULATION TESTING MARKET, BY APPLICATION, 2019–2032 (USD BILLION)
TABLE 51 EUROPE: BLOOD COAGULATION TESTING MARKET, FOR INHERITED BLEEDING DISORDERS, BY TYPE, 2019–2032 (USD BILLION)
TABLE 52 EUROPE: BLOOD COAGULATION TESTING MARKET, BY TEST TYPE, 2019–2032 (USD BILLION)
TABLE 53 EUROPE: BLOOD COAGULATION TESTING MARKET, BY END USER, 2019–2032 (USD BILLION)
TABLE 54 GERMANY: BLOOD COAGULATION TESTING MARKET, BY PRODUCT, 2019–2032 (USD BILLION)
TABLE 55 GERMANY: BLOOD COAGULATION TESTING MARKET, FOR CONSUMABLES, BY TYPE, 2019–2032 (METRIC TON)
TABLE 56 GERMANY: BLOOD COAGULATION TESTING MARKET, BY APPLICATION, 2019–2032 (USD BILLION)
TABLE 57 GERMANY: BLOOD COAGULATION TESTING MARKET, FOR INHERITED BLEEDING DISORDERS, BY TYPE, 2019–2032 (USD BILLION)
TABLE 58 GERMANY: BLOOD COAGULATION TESTING MARKET, BY TEST TYPE, 2019–2032 (USD BILLION)
TABLE 59 GERMANY: BLOOD COAGULATION TESTING MARKET, BY END USER, 2019–2032 (USD BILLION)
TABLE 60 FRANCE: BLOOD COAGULATION TESTING MARKET, BY PRODUCT, 2019–2032 (USD BILLION)
TABLE 61 FRANCE: BLOOD COAGULATION TESTING MARKET, FOR CONSUMABLES, BY TYPE, 2019–2032 (METRIC TON)
TABLE 62 FRANCE: BLOOD COAGULATION TESTING MARKET, BY APPLICATION, 2019–2032 (USD BILLION)
TABLE 63 FRANCE: BLOOD COAGULATION TESTING MARKET, FOR INHERITED BLEEDING DISORDERS, BY TYPE, 2019–2032 (USD BILLION)
TABLE 64 FRANCE: BLOOD COAGULATION TESTING MARKET, BY TEST TYPE, 2019–2032 (USD BILLION)
TABLE 65 FRANCE: BLOOD COAGULATION TESTING MARKET, BY END USER, 2019–2032 (USD BILLION)
TABLE 66 UK: BLOOD COAGULATION TESTING MARKET, BY PRODUCT, 2019–2032 (USD BILLION)
TABLE 67 UK: BLOOD COAGULATION TESTING MARKET, FOR CONSUMABLES, BY TYPE, 2019–2032 (METRIC TON)
TABLE 68 UK: BLOOD COAGULATION TESTING MARKET, BY APPLICATION, 2019–2032 (USD BILLION)
TABLE 69 UK: BLOOD COAGULATION TESTING MARKET, FOR INHERITED BLEEDING DISORDERS, BY TYPE, 2019–2032 (USD BILLION)
TABLE 70 UK: BLOOD COAGULATION TESTING MARKET, BY TEST TYPE, 2019–2032 (USD BILLION)
TABLE 71 UK: BLOOD COAGULATION TESTING MARKET, BY END USER, 2019–2032 (USD BILLION)
TABLE 72 ITALY: BLOOD COAGULATION TESTING MARKET, BY PRODUCT, 2019–2032 (USD BILLION)
TABLE 73 ITALY: BLOOD COAGULATION TESTING MARKET, FOR CONSUMABLES, BY TYPE, 2019–2032 (METRIC TON)
TABLE 74 ITALY: BLOOD COAGULATION TESTING MARKET, BY APPLICATION, 2019–2032 (USD BILLION)
TABLE 75 ITALY: BLOOD COAGULATION TESTING MARKET, FOR INHERITED BLEEDING DISORDERS, BY TYPE, 2019–2032 (USD BILLION)
TABLE 76 ITALY: BLOOD COAGULATION TESTING MARKET, BY TEST TYPE, 2019–2032 (USD BILLION)
TABLE 77 ITALY: BLOOD COAGULATION TESTING MARKET, BY END USER, 2019–2032 (USD BILLION)
TABLE 78 SPAIN: BLOOD COAGULATION TESTING MARKET, BY PRODUCT, 2019–2032 (USD BILLION)
TABLE 79 SPAIN: BLOOD COAGULATION TESTING MARKET, FOR CONSUMABLES, BY TYPE, 2019–2032 (METRIC TON)
TABLE 80 SPAIN: BLOOD COAGULATION TESTING MARKET, BY APPLICATION, 2019–2032 (USD BILLION)
TABLE 81 SPAIN: BLOOD COAGULATION TESTING MARKET, FOR INHERITED BLEEDING DISORDERS, BY TYPE, 2019–2032 (USD BILLION)
TABLE 82 SPAIN: BLOOD COAGULATION TESTING MARKET, BY TEST TYPE, 2019–2032 (USD BILLION)
TABLE 83 SPAIN: BLOOD COAGULATION TESTING MARKET, BY END USER, 2019–2032 (USD BILLION)
TABLE 84 REST OF EUROPE: BLOOD COAGULATION TESTING MARKET, BY PRODUCT, 2019–2032 (USD BILLION)
TABLE 85 REST OF EUROPE: BLOOD COAGULATION TESTING MARKET, FOR CONSUMABLES, BY TYPE, 2019–2032 (METRIC TON)
TABLE 86 REST OF EUROPE: BLOOD COAGULATION TESTING MARKET, BY APPLICATION, 2019–2032 (USD BILLION)
TABLE 87 REST OF EUROPE: BLOOD COAGULATION TESTING MARKET, FOR INHERITED BLEEDING DISORDERS, BY TYPE, 2019–2032 (USD BILLION)
TABLE 88 REST OF EUROPE: BLOOD COAGULATION TESTING MARKET, BY TEST TYPE, 2019–2032 (USD BILLION)
TABLE 89 REST OF EUROPE: BLOOD COAGULATION TESTING MARKET, BY END USER, 2019–2032 (USD BILLION)
TABLE 90 ASIA-PACIFIC: BLOOD COAGULATION TESTING MARKET, BY COUNTRY, 2019–2032 (USD BILLION)
TABLE 91 ASIA-PACIFIC: BLOOD COAGULATION TESTING MARKET, BY PRODUCT, 2019–2032 (USD BILLION)
TABLE 92 ASIA-PACIFIC: BLOOD COAGULATION TESTING MARKET, FOR CONSUMABLES, BY TYPE, 2019–2032 (METRIC TON)
TABLE 93 ASIA-PACIFIC: BLOOD COAGULATION TESTING MARKET, BY APPLICATION, 2019–2032 (USD BILLION)
TABLE 94 ASIA-PACIFIC: BLOOD COAGULATION TESTING MARKET, FOR INHERITED BLEEDING DISORDERS, BY TYPE, 2019–2032 (USD BILLION)
TABLE 95 ASIA-PACIFIC: BLOOD COAGULATION TESTING MARKET, BY TEST TYPE, 2019–2032 (USD BILLION)
TABLE 96 ASIA-PACIFIC: BLOOD COAGULATION TESTING MARKET, BY END USER, 2019–2032 (USD BILLION)
TABLE 97 CHINA: BLOOD COAGULATION TESTING MARKET, BY PRODUCT, 2019–2032 (USD BILLION)
TABLE 98 CHINA: BLOOD COAGULATION TESTING MARKET, FOR CONSUMABLES, BY TYPE, 2019–2032 (METRIC TON)
TABLE 99 CHINA: BLOOD COAGULATION TESTING MARKET, BY APPLICATION, 2019–2032 (USD BILLION)
TABLE 100 CHINA: BLOOD COAGULATION TESTING MARKET, FOR INHERITED BLEEDING DISORDERS, BY TYPE, 2019–2032 (USD BILLION)
TABLE 101 CHINA: BLOOD COAGULATION TESTING MARKET, BY TEST TYPE, 2019–2032 (USD BILLION)
TABLE 102 CHINA: BLOOD COAGULATION TESTING MARKET, BY END USER, 2019–2032 (USD BILLION)
TABLE 103 INDIA: BLOOD COAGULATION TESTING MARKET, BY PRODUCT, 2019–2032 (USD BILLION)
TABLE 104 INDIA: BLOOD COAGULATION TESTING MARKET, FOR CONSUMABLES, BY TYPE, 2019–2032 (METRIC TON)
TABLE 105 INDIA: BLOOD COAGULATION TESTING MARKET, BY APPLICATION, 2019–2032 (USD BILLION)
TABLE 106 INDIA: BLOOD COAGULATION TESTING MARKET, FOR INHERITED BLEEDING DISORDERS, BY TYPE, 2019–2032 (USD BILLION)
TABLE 107 INDIA: BLOOD COAGULATION TESTING MARKET, BY TEST TYPE, 2019–2032 (USD BILLION)
TABLE 108 INDIA: BLOOD COAGULATION TESTING MARKET, BY END USER, 2019–2032 (USD BILLION)
TABLE 109 JAPAN: BLOOD COAGULATION TESTING MARKET, BY PRODUCT, 2019–2032 (USD BILLION)
TABLE 110 JAPAN: BLOOD COAGULATION TESTING MARKET, FOR CONSUMABLES, BY TYPE, 2019–2032 (METRIC TON)
TABLE 111 JAPAN: BLOOD COAGULATION TESTING MARKET, BY APPLICATION, 2019–2032 (USD BILLION)
TABLE 112 JAPAN: BLOOD COAGULATION TESTING MARKET, FOR INHERITED BLEEDING DISORDERS, BY TYPE, 2019–2032 (USD BILLION)
TABLE 113 JAPAN: BLOOD COAGULATION TESTING MARKET, BY TEST TYPE, 2019–2032 (USD BILLION)
TABLE 114 JAPAN: BLOOD COAGULATION TESTING MARKET, BY END USER, 2019–2032 (USD BILLION)
TABLE 115 AUSTRALIA: BLOOD COAGULATION TESTING MARKET, BY PRODUCT, 2019–2032 (USD BILLION)
TABLE 116 AUSTRALIA: BLOOD COAGULATION TESTING MARKET, FOR CONSUMABLES, BY TYPE, 2019–2032 (METRIC TON)
TABLE 117 AUSTRALIA: BLOOD COAGULATION TESTING MARKET, BY APPLICATION, 2019–2032 (USD BILLION)
TABLE 118 AUSTRALIA: BLOOD COAGULATION TESTING MARKET, FOR INHERITED BLEEDING DISORDERS, BY TYPE, 2019–2032 (USD BILLION)
TABLE 119 AUSTRALIA: BLOOD COAGULATION TESTING MARKET, BY TEST TYPE, 2019–2032 (USD BILLION)
TABLE 120 AUSTRALIA: BLOOD COAGULATION TESTING MARKET, BY END USER, 2019–2032 (USD BILLION)
TABLE 121 SOUTH KOREA: BLOOD COAGULATION TESTING MARKET, BY PRODUCT, 2019–2032 (USD BILLION)
TABLE 122 SOUTH KOREA: BLOOD COAGULATION TESTING MARKET, FOR CONSUMABLES, BY TYPE, 2019–2032 (METRIC TON)
TABLE 123 SOUTH KOREA: BLOOD COAGULATION TESTING MARKET, BY APPLICATION, 2019–2032 (USD BILLION)
TABLE 124 SOUTH KOREA: BLOOD COAGULATION TESTING MARKET, FOR INHERITED BLEEDING DISORDERS, BY TYPE, 2019–2032 (USD BILLION)
TABLE 125 SOUTH KOREA: BLOOD COAGULATION TESTING MARKET, BY TEST TYPE, 2019–2032 (USD BILLION)
TABLE 126 SOUTH KOREA: BLOOD COAGULATION TESTING MARKET, BY END USER, 2019–2032 (USD BILLION)
TABLE 127 REST OF ASIA-PACIFIC: BLOOD COAGULATION TESTING MARKET, BY PRODUCT, 2019–2032 (USD BILLION)
TABLE 128 REST OF ASIA-PACIFIC: BLOOD COAGULATION TESTING MARKET, FOR CONSUMABLES, BY TYPE, 2019–2032 (METRIC TON)
TABLE 129 REST OF ASIA-PACIFIC: BLOOD COAGULATION TESTING MARKET, BY APPLICATION, 2019–2032 (USD BILLION)
TABLE 130 REST OF ASIA-PACIFIC: BLOOD COAGULATION TESTING MARKET, FOR INHERITED BLEEDING DISORDERS, BY TYPE, 2019–2032 (USD BILLION)
TABLE 131 REST OF ASIA-PACIFIC: BLOOD COAGULATION TESTING MARKET, BY TEST TYPE, 2019–2032 (USD BILLION)
TABLE 132 REST OF ASIA-PACIFIC: BLOOD COAGULATION TESTING MARKET, BY END USER, 2019–2032 (USD BILLION)
TABLE 133 REST OF THE WORLD BLOOD COAGULATION TESTING MARKET, BY REGION, 2019–2032 (USD BILLION)
TABLE 134 REST OF THE WORLD: BLOOD COAGULATION TESTING MARKET, BY PRODUCT, 2019–2032 (USD BILLION)
TABLE 135 REST OF THE WORLD: BLOOD COAGULATION TESTING MARKET, FOR CONSUMABLES, BY TYPE, 2019–2032 (USD BILLION)
TABLE 136 REST OF THE WORLD: BLOOD COAGULATION TESTING MARKET, BY APPLICATION, 2019–2032 (USD BILLION)
TABLE 137 REST OF THE WORLD: BLOOD COAGULATION TESTING MARKET, FOR INHERITED BLEEDING DISORDER, BY TYPE 2019–2032 (USD BILLION)
TABLE 138 REST OF THE WORLD: BLOOD COAGULATION TESTING MARKET, BY TEST TYPE 2019–2032 (USD BILLION)
TABLE 139 REST OF THE WORLD: BLOOD COAGULATION TESTING MARKET, BY END USER, 2019–2032 (USD BILLION)
TABLE 140 MIDDLE EAST: BLOOD COAGULATION TESTING MARKET, BY PRODUCT, 2019–2032 (USD BILLION)
TABLE 141 MIDDLE EAST: BLOOD COAGULATION TESTING MARKET, FOR CONSUMABLES, BY TYPE, 2019–2032 (USD BILLION)
TABLE 142 MIDDLE EAST: BLOOD COAGULATION TESTING MARKET, BY APPLICATION, 2019–2032 (USD BILLION)
TABLE 143 MIDDLE EAST: BLOOD COAGULATION TESTING MARKET, FOR INHERITED BLEEDING DISORDER, BY TYPE 2019–2032 (USD BILLION)
TABLE 144 MIDDLE EAST: BLOOD COAGULATION TESTING MARKET, BY TEST TYPE 2019–2032 (USD BILLION)
TABLE 145 MIDDLE EAST: BLOOD COAGULATION TESTING MARKET, BY END USER, 2019–2032 (USD BILLION)
TABLE 146 AFRICA: BLOOD COAGULATION TESTING MARKET, BY PRODUCT, 2019–2032 (USD BILLION)
TABLE 147 AFRICA: BLOOD COAGULATION TESTING MARKET, FOR CONSUMABLES, BY TYPE, 2019–2032 (USD BILLION)
TABLE 148 AFRICA: BLOOD COAGULATION TESTING MARKET, BY APPLICATION, 2019–2032 (USD BILLION)
TABLE 149 AFRICA: BLOOD COAGULATION TESTING MARKET, FOR INHERITED BLEEDING DISORDER, BY TYPE 2019–2032 (USD BILLION)
TABLE 150 AFRICA: BLOOD COAGULATION TESTING MARKET, BY TEST TYPE 2019–2032 (USD BILLION)
TABLE 151 AFRICA: BLOOD COAGULATION TESTING MARKET, BY END USER, 2019–2032 (USD BILLION)
TABLE 152 LATIN AMERICA: BLOOD COAGULATION TESTING MARKET, BY PRODUCT, 2019–2032 (USD BILLION)
TABLE 153 LATIN AMERICA: BLOOD COAGULATION TESTING MARKET, FOR CONSUMABLES, BY TYPE, 2019–2032 (USD BILLION)
TABLE 154 LATIN AMERICA: BLOOD COAGULATION TESTING MARKET, BY APPLICATION, 2019–2032 (USD BILLION)
TABLE 155 LATIN AMERICA: BLOOD COAGULATION TESTING MARKET, FOR INHERITED BLEEDING DISORDER, BY TYPE 2019–2032 (USD BILLION)
TABLE 156 LATIN AMERICA: BLOOD COAGULATION TESTING MARKET, BY TEST TYPE 2019–2032 (USD BILLION)
TABLE 157 LATIN AMERICA: BLOOD COAGULATION TESTING MARKET, BY END USER, 2019–2032 (USD BILLION)
TABLE 158 EXPANSION
TABLE 159 AGREEMENT
TABLE 160 PRODUCT LAUNCH
TABLE 161 APPROVAL
TABLE 162 ACQUISITION
TABLE 163 PRODUCT RECOGNISTION
TABLE 164 F. HOFFMANN-LA ROCHE LTD.: PRODUCTS OFFERED
TABLE 165 F. HOFFMANN-LA ROCHE LTD.: KEY DEVELOPMENTS
TABLE 166 MICROPOINT BIOTECHNOLOGIES CO., LTD.: PRODUCTS OFFERED
TABLE 167 HEMOSONICS, LLC: PRODUCTS OFFERED
TABLE 168 HEMOSONICS, LLC: KEY DEVELOPMENTS
TABLE 169 HELENA LABORATORIES CORPORATION: PRODUCTS OFFERED
TABLE 170 SYSMEX CORPORATION: PRODUCTS OFFERED
TABLE 171 SYSMEX CORPORATION: KEY DEVELOPMENTS
TABLE 172 WERFEN: PRODUCTS OFFERED
TABLE 173 WERFEN: KEY DEVELOPMENTS
TABLE 174 MERIL LIFE SCIENCES PVT. LTD.: PRODUCTS OFFERED
TABLE 175 THERMO FISHER SCIENTIFIC, INC.: PRODUCTS OFFERED
TABLE 176 SIEMENS HEALTHINEERS AG: PRODUCT OFFERED
TABLE 177 SIEMENS HEALTHINEERS: KEY DEVELOPMENTS
LIST OF FIGURES
FIGURE 1 GLOBAL BLOOD COAGULATION TESTING MARKET: STRUCTURE
FIGURE 2 GLOBAL BLOOD COAGULATION TESTING MARKET: MARKET GROWTH FACTOR ANALYSIS (2024-2032)
FIGURE 3 DRIVER IMPACT ANALYSIS (2023-2032)
FIGURE 4 RESTRAINT IMPACT ANALYSIS (2022-2032)
FIGURE 5 NUMBER OF PEOPLE AGED 60 YEARS OR OVER IN ASIA-PACIFIC, BY SUBREGION, 2022, 2030 AND 2050
FIGURE 6 PORTER'S FIVE FORCES ANALYSIS: GLOBAL BLOOD COAGULATION TESTING MARKET
FIGURE 7 GLOBAL BLOOD COAGULATION TESTING MARKET, 2023 & 2032 (USD BILLION)
FIGURE 8 GLOBAL BLOOD COAGULATION TESTING MARKET, BY PRODUCT, 2023 & 2032 (USD BILLION)
FIGURE 9 GLOBAL BLOOD COAGULATION TESTING MARKET SHARE (%), BY PRODUCT, 2023
FIGURE 10 GLOBAL BLOOD COAGULATION TESTING MARKET, APPLICATION, 2023 & 2032 (USD BILLION)
FIGURE 11 GLOBAL BLOOD COAGULATION TESTING MARKET, BY APPLICATION, 2023 & 2032 (USD BILLION)
FIGURE 12 GLOBAL BLOOD COAGULATION TESTING MARKET SHARE (%), BY APPLICATION, 2023
FIGURE 13 GLOBAL BLOOD COAGULATION TESTING MARKET, TEST TYPE, 2023 & 2032 (USD BILLION)
FIGURE 14 GLOBAL BLOOD COAGULATION TESTING MARKET, BY TEST TYPE, 2023 & 2032 (USD BILLION)
FIGURE 15 GLOBAL BLOOD COAGULATION TESTING MARKET SHARE (%), BY TEST TYPE, 2023
FIGURE 16 GLOBAL BLOOD COAGULATION TESTING MARKET, END USER, 2023 & 2032 (USD BILLION)
FIGURE 17 GLOBAL BLOOD COAGULATION TESTING MARKET, BY END USER, 2023 & 2032 (USD BILLION)
FIGURE 18 GLOBAL BLOOD COAGULATION TESTING MARKET SHARE (%), BY END USER, 2023
FIGURE 19 GLOBAL BLOOD COAGULATION TESTING MARKET, BY REGION, 2023 & 2032 (USD BILLION)
FIGURE 20 GLOBAL BLOOD COAGULATION TESTING MARKET SHARE (%), BY REGION, 2023
FIGURE 21 NORTH AMERICA MARKET ANALYSIS: BLOOD COAGULATION TESTING MARKET, 2019-2032
FIGURE 22 NORTH AMERICA: BLOOD COAGULATION TESTING MARKET, BY COUNTRY, 2023 & 2032 (USD BILLION)
FIGURE 23 NORTH AMERICA: BLOOD COAGULATION TESTING MARKET SHARE (%), BY COUNTRY, 2023
FIGURE 24 EUROPE MARKET ANALYSIS: BLOOD COAGULATION TESTING MARKET, 2019-2032 (USD BILLION)
FIGURE 25 EUROPE: BLOOD COAGULATION TESTING MARKET SHARE, BY COUNTRY, 2023 & 2032 (USD BILLION)
FIGURE 26 EUROPE: BLOOD COAGULATION TESTING MARKET SHARE, BY COUNTRY, 2023 (%)
FIGURE 27 ASIA-PACIFIC MARKET ANALYSIS: BLOOD COAGULATION TESTING MARKET, 2019-2032 (USD BILLION)
FIGURE 28 ASIA-PACIFIC: BLOOD COAGULATION TESTING MARKET SHARE, BY COUNTRY, 2023 & 2032 (USD BILLION)
FIGURE 29 ASIA-PACIFIC: BLOOD COAGULATION TESTING MARKET SHARE, BY COUNTRY, 2023 (%)
FIGURE 30 REST OF THE WORLD MARKET ANALYSIS: BLOOD COAGULATION TESTING MARKET, 2019-2032 (USD BILLION)
FIGURE 31 REST OF THE WORLD: BLOOD COAGULATION TESTING MARKET SHARE, BY COUNTRY, 2023 & 2032 (USD BILLION)
FIGURE 32 REST OF THE WORLD: BLOOD COAGULATION TESTING MARKET SHARE, BY COUNTRY, 2023 (%)
FIGURE 33 GLOBAL BLOOD COAGULATION TESTING MARKET PLAYERS: COMPETITIVE ANALYSIS, 2023
FIGURE 34 COMPETITOR DASHBOARD: GLOBAL BLOOD COAGULATION TESTING MARKET
FIGURE 35 F. HOFFMANN-LA ROCHE LTD.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 36 F. HOFFMANN-LA ROCHE LTD.: SWOT ANALYSIS
FIGURE 37 SYSMEX CORPORATION: SWOT ANALYSIS
FIGURE 38 SYSMEX CORPORATION: SWOT ANALYSIS
FIGURE 39 WERFEN: SWOT ANALYSIS
FIGURE 40 THERMO FISHER SCIENTIFIC, INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 41 THERMO FISHER SCIENTIFIC, INC.: SWOT ANALYSIS
FIGURE 42 SIEMENS HEALTHINEERS AG: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 43 SIEMENS HEALTHINEERS AG: SWOT ANALYSIS
